National
Cancer Institute Offers Funding for
Small Businesses more
|
|
|
Events Column |
|
|
4/20
9:00 am - 5:00pm
CT Venture Group. "Preparing for Investors: An Executive
Workshop on How to Make Your Business Concept Attractive to an
Investor or Licensee." CT Convention Center, Hartford. more
|
|
|
|
4/20-23
2010 National SBIR
Conference. Connecticut Convention Center, 100 Columbus
Boulevard, Hartford. more
|
|
|
4/21
7:30 am - 5:15 pm
Yale CME Conference: "Sexuality and Cancer Survivorhip."
New Haven Lawn Club, 193 Whitney Avenue, New Haven more
|
|
|
4/22
11:00 am - 12:30
Meet a Nobel Prize Scientist and Tour the New CURE Mobile Lab!
Capitol Building, South Entrance, Hartford. more
|
|
|
4/27
4:00 pm - 6:00 pm
Professor Uwe Reinhardt, top health care economist, at CURE
Annual Meeting. Presidents Room, Woolsey Hall, Yale
University, 500 College Street, New Haven more
|
|
|
|
5/5
MIT Enterprise Forum of CT more
|
|
|
|
5/5-6
Crossroads 2010. The largest venture fair in the eastern U.S.,
now in its 17th year. Omni Hotel at Yale, New Haven. more
|
|
|
5/12
4:00 pm - 6:00 pm
CURE/Yale BioHaven
Entrepreneurship Series: JS Genetics. Anlyan Center, Yale
Medical School, New Haven. more
|
|
|
5/26
4:00 pm - 6:00 pm
CURE/Yale BioHaven
Entrepreneurship Series: Kolltan Pharmaceuticals. Anlyan
Center, Yale Medical School, New Haven. more
|
|
|
6/2
4:30 pm - 7:30 pm
CVG: Partnering for Growth, UConn's Technology Transfer
Platform. UConn Health Center, 400 Farmington Ave, Farmington.
more
|
|
|
|
|
Reinhardt
of Yale & Princeton, Health Care Expert,
Is Guest Speaker at CURE Annual Meeting April 27
From the desk of Paul
Pescatello, President and CEO of CURE
 I’m
delighted to report that at CURE’s Annual Meeting April 27, our guest speaker will be Professor Uwe Reinhardt of Princeton, one of the country’s foremost experts on the U.S. health care system and health care reform.
In his talk, “Health
Care Reform and Innovation,” Professor Reinhardt plans to
examine how health care reform will play out over the next
four years, and its impact on biopharma R&D and
innovation.
For the full story |
|
|
Reinhardt,
Health Care Authority, to Address CURE
 Attendance is by invitation
only. To the extent seats
become available, they will be set aside for distribution to
members of the public. Following
Professor Reinhardt’s remarks, CURE will present the CURE
Award for Excellence and the CURE Atlas Award for Venture
Capital Achievement to this year's winners, selected from
among Connecticut organizations and individuals.
For the full story
|
|
|
Meet a Nobel
Prize Scientist April 22 in Hartford
In observance of Bring Your
Child to Work Day, CURE and Boehringer Ingelheim
Pharmaceuticals, Inc cordially invite you to visit the new
BioScience Explorations mobile laboratory and meet one of
Connecticut's most distinguished scientists, Dr. Thomas
Steitz, the winner of the 2009 Nobel Prize in chemistry.
For the full story
|
|
|
CURE Speaks Against 'Gifts' Bill
Calling it “a bill in search of a problem,” Paul Pescatello, president of CURE, spoke against Raised Bill No. 270 in testimony March 1 before the Committee on Public Health of the Connecticut General Assembly.
The bill purports to address the “problem” of gifts by biopharma companies to doctors and other health care providers – but that issue has already been successfully addressed and regulated by various other bodies, Pescatello said.
For the full story
|
|
|
Health Network
Plans Fortify CT Bioscience Sector
 Plans
were announced March 9 to establish the UConn Health
Network, a partnership with area hospitals aimed at creating
jobs and and improving access to quality health care in the
state. A key feature of the Network would be a Bioscience
Enterprise Zone, which would offer tax breaks to private
companies that create jobs and work with UConn Health Network
partners.
For the full story
|
|
|
Arbor Fuel
Presents at CURE/Yale BioHaven
 Continuing
the 2009-2010 CURE/Yale BioHaven Entrepreneurship seminar
series was a presentation February 25 by Arbor Fuel Inc. Arbor
Fuel, based in Farmington, is using biotechnology to generate
alternative fuels.
For the full story
|
|
|
CURE/Yale BioHaven
Presents CardioPhotonics & Advanced Orthopedic
Technologies
 Continuing the 2009-2010 CURE/Yale BioHaven Entrepreneurship seminar series
were presentations January 28 by two companies, Advanced
Orthopedic Technologies and CardioPhotonics.
For the full story
|
|
|
Connecticut
Stem Cell Research Roundup
Connecticut
– the stem cell state
On March 11, 2010,
testimony was heard before the
Appropriations Committee of the Connecticut General Assembly
on the value of Connecticut’s Stem Cell Research Fund.
Among those speaking were Myron
Genel of Yale, Marc
Lalande of UConn, Haifan Lin of Yale, and Paul Pescatello of
CURE.
For the full story |
CURE Member News Digest
 454
Life Sciences aids in presenting Kalahari gene sequence
Achillion announces more Phase 2
results for elvucitabine
Affomix collaborates with City of
Hope
Alexion appoints Andreas Rummelt to
Board of Directors
Amarin names Jan van Heek to
Board of Directors
Boehringer Ingelheim reports FDA
approval of Mirapex ER®
Bristol-Myers Squibb cites
positive Apixaban study
Cantor Colburn named top firm by
Intellectual Property Today
Cara Therapeutics reports positive
Phase 2 data re CR845
Connecticut Innovations makes $1.5
loan the Helix Therapeutics
Hartford Hospital names Betsy
Boatman a vice president
Helix Therapeutics gets more
venture capital funding
HistoRx in deal with Genoptix
Ipsogen takes more Stamford space
MannKind names
James Shannon to Board of Directors
NanoViricides signs deal with
Harris lab
New England Biotech Association
elects Pescatello president
Optherion in
deal with Sequenom
Pfizer reports
CDC recommendation of Prevnar 13™
PhRMA
reports
on aid to Haiti
Protein
Sciences
names Dr. Manon Cox president & CEO
Rib-X names Leuchtenberger
president & CEO
SBIR-CT to host national convention
in Hartford
UConn to dedicate new
research building in Farmington
Yale neuroscientist
generates color-coded proteins
For
the full story |
|
